Crispr Therapeutics shares owned by Foster Dykema Cabot & Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Foster Dykema Cabot & Partners
from 13F filings
Historical chart of Foster Dykema Cabot & Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Foster Dykema Cabot & Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Foster Dykema Cabot & Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $648 | 10 | 64.80 |
| 2025-06-30 | $486 | 10 | 48.60 |
| 2025-03-31 | $340 | 10 | 34.00 |
| 2024-12-31 | $394 | 10 | 39.40 |
| 2024-09-30 | $470 | 10 | 47.00 |
| 2024-03-31 | $682 | 10 | 68.20 |
More positions owned by Foster Dykema Cabot & Partners
View all positions for Foster Dykema Cabot & Partners